Skip to main content
. 2021 Aug 28;14(9):863. doi: 10.3390/ph14090863

Figure 1.

Figure 1

Cannabidiol (CBD) does not prevent streptozotocin (STZ)-induced diabetes. (a) Mid-study (3 days of STZ treatment) and (b) end-of-study (7 days of STZ treatment) non-fasting blood glucose levels in healthy control (control), vehicle-STZ- (Veh-STZ), and CBD-STZ-treated mice. (c) Fasting blood glucose at the end of the study. (d) Intraperitoneal glucose tolerance test (IPGTT) in vehicle-STZ and CBD-STZ-treated mice compared to control at the end of the study. (e) The area under the curve of the IPGTT was calculated using the trapezoidal rule. Values are expressed as mean ± SEM (n = 6–7 animals per group). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. vehicle-citrate buffer-treated mice (control).